Eargo Inc

NASDAQ EAR

Data sourced from

and

Download Data

Eargo Inc Cash and Short-Term Investments for the year ending December 31, 2022: USD 101.24 M

Eargo Inc Cash and Short-Term Investments is USD 101.24 M for the year ending December 31, 2022, a -8.38% change year over year. Cash and Short-Term Investments is the sum of cash and short-term investments, representing the company's liquid assets.

Eargo Inc Cash and Short-Term Investments for the year ending December 31, 2021 was USD 110.50 M, a -47.92% change year over year.
Eargo Inc Cash and Short-Term Investments for the year ending December 31, 2020 was USD 212.19 M, a 1,485.36% change year over year.
Eargo Inc Cash and Short-Term Investments for the year ending December 31, 2019 was USD 13.38 M, a -73.78% change year over year.
Eargo Inc Cash and Short-Term Investments for the year ending December 31, 2018 was USD 51.05 M.

NASDAQ: EAR

Eargo Inc

CEO	Mr. Christian Gormsen
IPO Date	Oct. 16, 2020
Location	United States
Headquarters	2665 North First Street, San Jose, CA, United States, 95134
Employees	243
Sector	Healthcare
Industry	Medical devices

Description

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Key trends